NCT01678235View on ClinicalTrials.gov

Insulin Glulisine and Aspart in Postprandial Glycemic Control After High-GI Meal in Children With Type 1 Diabetes Mellitus

PHASE4CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Type 1 Diabetes Mellitus
Interventions
DRUG

Insulin glulisine

DRUG

Insulin aspart

Trial Locations (1)

01-184

Department of Pediatrics, Medical University of Warsaw, Poland, Warsaw

All Listed Sponsors
lead

Medical University of Warsaw

OTHER

NCT01678235 - Insulin Glulisine and Aspart in Postprandial Glycemic Control After High-GI Meal in Children With Type 1 Diabetes Mellitus | Biotech Hunter | Biotech Hunter